Skip to main content

Table 3 Detection of recurrence

From: Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection

  

No. of patients (N = 50)

Recurrence

Yes

34 (68%)

 

No

16 (32%)

Pathologic confirmation

6 (12%)

Clinical confirmation

44 (88%)

  

No. of lesions (n = 39)

Recurrence site (multiple counted)

Locoregional recurrence (Liver or anastomosis site)

16 (41%)

 

Distant metastasis

23 (60%)

 

   Lymph node

16 (42%)

 

   Peritoneum

3 (8%)

 

   Other (Lung, bone)

4 (10%)